Table 1.
Comparison of Baseline Variables for Males (n=176) and Females (n=221)
| Males (N=176) | Females (N=221) | ||
|---|---|---|---|
| Demographics | |||
| Age | Mean(SD) | 47.7 (15.5) | 40.6 (14.3) |
| Race | White | 157 (89.2%) | 194 (87.8%) |
| Black | 9 (5.1%) | 7 (3.2%) | |
| Asian | 4 (2.3%) | 4 (1.8%) | |
| Multi Race | 1 (0.6%) | 10 (4.5%) | |
| Other | 4 (2.3%) | 5 (2.3%) | |
| Ethnicity | Hispanic | 6 (3.4%) | 15 (6.8%) |
| Non-Hispanic | 169 (96.0%) | 206 (93.2%) | |
| Income | $10,000 or less | 9 (5.1%) | 28 (12.7%) |
| $10,001 to $25,000 | 10 (5.7%) | 22 (10.0%) | |
| $25,001 to $50,000 | 22 (12.5%) | 42 (19.0%) | |
| $50,001 to $100,000 | 57 (32.4%) | 59 (26.7%) | |
| More than $100,000 | 65 (36.9%) | 48 (21.7%) | |
| Duration of symptom (yrs) | Mean(SD) | 8.1 (10.9) | 9.1 (10.3) |
| Duration of symptom (n) | <2 yr | 81 (46.0%) | 83 (37.6%) |
| >2yr | 95 (54.0%) | 138 (62.4%) | |
| Symptom Severity | |||
| Pain Severity at Baseline | Mean(SD) | 11.8 (5.6) | 14.3 (5.8) |
| Urinary Severity at Baseline | Mean(SD) | 10.0 (5.9) | 12.2 (6.1) |
| CMSI | |||
| CMSI Non-Urological Symptoms | Mean(SD) | 5.9 (4.7) | 9.2 (7.7) |
| Body Map | |||
| Total Sites Non-pelvic (0–42) | Mean(SD) | 2.9 (3.5) | 5.4 (7.3) |
| Head pain (n) | none | 123 (69.9%) | 115 (52.0%) |
| present | 53 (30.1%) | 106 (48.0%) | |
| SF-12 | |||
| Physical Component (PCS) (0–100) | Mean(SD) | 50.0 (9.1) | 45.4 (10.7) |
| Mental Component (MCS) (0–100) | Mean(SD) | 45.0 (10.5) | 43.7 (10.0) |
| PROMIS Scales | |||
| Fatigue (0–100) | Mean(SD) | 52.2 (7.7) | 56.5 (8.9) |
| Sleep disturbance(0–100) | Mean(SD) | 52.5 (8.9) | 55.6 (9.3) |
| HADS | |||
| HADS: Depression (0–21) | Mean(SD) | 5.3 (4.0) | 5.2 (4.2) |
| HADS: Anxiety (0–21) | Mean(SD) | 7.3 (4.2) | 7.8 (4.7) |
| CSQ: Catastrophizing (CAT) | |||
| CSQ: CAT (0–36) | Mean(SD) | 10.4 (8.5) | 13.9 (8.6) |
| PSS | |||
| PSS total (0–40) | Mean(SD) | 15.0 (7.0) | 17.0 (8.2) |
| SEAR | |||
| Total Score (0–100) | Mean(SD) | 47.6 (16.4) | 38.2 (15.1) |